Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults

Madan Anuradha; Segall Nathan; Ferguson Murdo; Frenette Louise; Kroll Robin; Friel Damien; Soni Jyoti; Li Ping; Innis Bruce L.; Schuind Anne

首页> 外文期刊>The Journal of Infectious Diseases >Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults

【24h】

Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults

机译：健康成年人中AS03佐剂的H7N9大流行性流感疫苗的免疫原性和安全性。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background. Almost 700 cases of human infection with avian influenza A/H7N9 have been reported since 2013. Pandemic preparedness strategies include H7N9 vaccine development.

机译：背景。自2013年以来，已经报告了近700例人类感染A / H7N9禽流感的病例。大流行防范策略包括开发H7N9疫苗。

著录项

来源
《The Journal of Infectious Diseases》 |2016年第11期|共11页
作者
Madan Anuradha; Segall Nathan; Ferguson Murdo; Frenette Louise; Kroll Robin; Friel Damien; Soni Jyoti; Li Ping; Innis Bruce L.; Schuind Anne;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
influenza; pandemic; H7N9; vaccine; AS03; adjuvant system; antigen sparing;

机译：流感;大流行;H7N9;疫苗;AS03;佐剂系统;抗原节约;

相似文献

外文文献
中文文献
专利

1. Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults [J] . Madan Anuradha, Segall Nathan, Ferguson Murdo, The Journal of Infectious Diseases . 2016,第11期

机译：健康成年人中AS03佐剂的H7N9大流行性流感疫苗的免疫原性和安全性。
2. Safety and immunogenicity of 2010-2011 A/H1N1 pdm09-containing trivalent inactivated influenza vaccine in adults previously given AS03-adjuvanted H1N1 2009 pandemic vaccine Results of a randomized trial [J] . David W. Scheifele, Marc Dionne, Brian J. Ward, Human vaccines . 2013,第1期

机译：2010-2011年含A / H1N1 pdm09的三价灭活流感疫苗的安全性和免疫原性在先前接受过AS03辅助的H1N1 2009大流行疫苗的成年人中
3. Safety and immunogenicity of 2010-2011 A/H1N1pdm09-containing trivalent inactivated influenza vaccine in adults previously given AS03-adjuvanted H1N1 2009 pandemic vaccine: Results of a randomized trial [J] . ScheifeleD.W., DionneM., WardB.J., Human vaccines & immunotherapeutics. . 2013,第1期

机译：2010-2011年含A / H1N1pdm09的三价灭活流感疫苗的安全性和免疫原性在先前接受过AS03辅助的H1N1 2009大流行疫苗的成年人中：一项随机试验的结果
4. A double-blind, randomized phase II trial of thesafety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults [C] . Shelly A. McNeil, Scott A. Halperin, Joanne M. Langley, Lancefield International Symposium on Streptococci and Streptococcal Diseases . 2006

机译：一种双盲，随机期II试验，对健康成人的26岁的26岁群体的疫苗疫苗
5. Analysis of a Potential A(H7N9) Influenza Pandemic Outbreak in the U.S [D] . Silva Sotillo, Walter A. 2017

机译：美国潜在的A（H7N9）流感大流行暴发分析
6. Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults [O] . Anuradha Madan, Nathan Segall, Murdo Ferguson, -1

机译：健康成年人中AS03佐剂的H7N9大流行性流感疫苗的免疫原性和安全性。
7. Immunogenicity and safety of an AS03-adjuvanted H5N1 pandemic influenza vaccine in Korean adults: A phase IV, randomized, open-label, controlled study [O] . Izurieta Patricia, Kim Woo Joo, Wie Seong-Heon, 2015

机译：AS03佐剂的H5N1大流行性流感疫苗在韩国成年人中的免疫原性和安全性：IV期，随机，开放标签，对照研究

Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults

摘要

著录项

相似文献

相关主题

期刊订阅